Expanding the Scope of Precision Care for Patients With HR-Positive Breast Cancers: Things You Should Know

Learn from expert faculty as they discuss application of recent clinical evidence to develop personalized treatment plans for HR-positive/HER2-negative early and advanced breast cancer the use of current and emerging oral targeted therapies and strategies to promote adherence with a downloadable slideset from a satellite symposium an on-demand webcast and expert commentary.

Share

Program Content

Activities

HR-Positive Early-Stage Breast Cancer
Assessing Risk and Individualizing Therapy in HR+/HER2- Early Breast Cancer
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: June 06, 2022

Expires: June 05, 2023

View Activity
HR-Positive Breast Cancer
Practical Management of Adverse Events and Strategies to Promote Adherence with Targeted Therapies in HR-Positive Breast Cancer
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: June 06, 2022

Expires: June 05, 2023

View Activity
HR-Positive Metastatic Breast Cancer
Selection and Sequencing of Targeted Therapy for HR+/HER2- Advanced/Metastatic Breast Cancer
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: June 07, 2022

Expires: June 06, 2023

View Activity

Activities

HR-Positive Breast Cancers
Expanding the Scope of Precision Care for Patients With HR-Positive Breast Cancers: Things You Should Know
Multimedia
Congratulations: You achieved a completion on 04/09/2022

Released: June 10, 2022

Expires: June 09, 2023

View Activity

Activities

Updates in HR+ Breast Cancer
Key Updates in the Treatment of Hormone Receptor–Positive Breast Cancer
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: July 18, 2022

Expires: July 17, 2023

View Activity

Faculty

cover img faculity

Komal Jhaveri, MD, FACP

Associate Attending
Breast Medicine Service and Early Drug Development Service
Section Head, Endocrine Therapy Research Program
Clinical Director, Early Drug Development Service
Department of Medicine
Associate Professor of Medicine
Weill Cornell Medical College
New York, New York

cover img faculity

Erica Mayer, MD, MPH

Director of Breast Cancer Clinical Research
Dana-Farber Cancer Institute
Associate Professor of Medicine
Harvard Medical School
Boston, Massachusetts

cover img faculity

Laura M. Spring, MD

Breast Medical Oncologist
Mass General Cancer Center
Harvard Medical School
Boston, Massachusetts

Provided by

ProCE Banner

Supporters

Supported by educational grants from

Lilly

Novartis Pharmaceuticals Corporation

Sanofi Genzyme